Opioid epidemic: Huge funding boost needed to close treatment gap
Administrative and insurance barriers continue to block access to treatment, AMA President-elect Susan R. Bailey, MD, tells Congress.
Get rid of market barriers to appropriate pain management
Health insurers, pharmacy benefit management companies and others are making it harder for physicians to provide appropriate care to patients living with pain.
AMA passes opioid policies to end barriers to non-opioid treatment
The AMA approved several opioid-related policies intended to put the focus of pain treatment back on patients and away from arbitrary third-party controls.
AMA president applauds members moving medicine forward
In her address at the AMA Annual Meeting, AMA President Barbara L. McAneny today outlined a number of advocacy victories from the past year.
Physician insight sorely needed for hard choices ahead: AMA president
AMA President Barbara L. McAneny, MD, is proud of the work the physicians are doing to repair our country’s broken health care system.
Physicians take steps against opioid epidemic, mortality rises
AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.
Doctors make progress on opioids, call on policymakers to do more
Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment.
AMA Opioid Task Force recommendations offer roadmap to policymakers
The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.
Patient Support & Advocacy
6 ways insurers drive the surprise-billing phenomenon
There is bipartisan support in Congress for action on so-called surprise billing—where patients unexpectedly receive a bill for care they thought their insurance covered.